Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer

IMPORTANCE: One-third of patients with papillary thyroid cancer (PTC) develop persistent or recurrent disease after initial therapy. Most patients with persistent or recurrent disease undergo reoperation, but the role of treatment with radioactive iodine (RAI) after reoperation is unclear. OBJECTIVE...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Surg
Autors principals: Hung, Matthew L., Wu, James X., Li, Ning, Livhits, Masha J., Yeh, Michael W.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583014/
https://ncbi.nlm.nih.gov/pubmed/30140908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2018.2659
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars